Moreover, another notable example is an MMP-2-sensitive system utilizing galactosylated liposomes loaded with MMP-2-cleavable PEG-peptide-DOPE (PEG-PD) for HCC-targeted therapy. Here, MMP2 is linked to hepatocellular carcinoma.